Hi Intheblack,Discount is now even larger, any ideas why? Maybe time to have a look over the performance compared to the likes of AFI, ARG, MIR etc.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling